Continuous Positive Airway Pressure as a Potential New Treatment for Cluster Headache
CPAP
1 other identifier
interventional
30
1 country
1
Brief Summary
Cluster headache is also called suicide headache due to excruciating nocturnal attacks. There are few treatment options available. Inhalation of oxygen has shown to abort the attacks. Continuous positive airway pressure (CPAP) is a machine used during sleep to treat respiratory failure. Automatic CPAP machines adjust the air pressure through the night to keep the upper airways patent. Single reports have shown a high prevalence of obstructive sleep apnea in people suffering from cluster headache, and positive effects of CPAP treatment, but no randomized controlled trial has been conducted so far. If proven effective CPAP would make an affordable treatment option for many patients within the existing healthcare system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 4, 2018
CompletedFirst Posted
Study publicly available on registry
January 12, 2018
CompletedStudy Start
First participant enrolled
January 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 21, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 21, 2019
CompletedMarch 31, 2020
March 1, 2020
1.6 years
January 4, 2018
March 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
change from baseline in number of cluster headache attacks per week at week 9-12
12 weeks
change from baseline in number of cluster headache attacks per week at week 21-24
24 weeks
Secondary Outcomes (20)
Change from baseline in the number of nightly cluster attacks per week at week 9-12
12 weeks
Change from baseline in the number of nightly cluster attacks per week at week 21-24
24 weeks
Change from baseline in cluster headache start time per week at week 9-12
12 weeks
Change from baseline in cluster headache start time per week at week 21-24
24 weeks
Change from baseline in the number of days with cluster headache per week at week 9-12
12 weeks
- +15 more secondary outcomes
Study Arms (2)
CPAP treatment
EXPERIMENTALContinuous Positive Airway Pressure (CPAP)
Sham-CPAP treatment
SHAM COMPARATORsham Continuous Positive Airway Pressure (sham-CPAP)
Interventions
standard automatic CPAP machine set on optimal automatic pressure
CPAP machine with pressure set below effective impact, i.e. low pressure of 4 cm H2O and adjustment of the ventilation mask
Eligibility Criteria
You may qualify if:
- Fulfils the diagnostic criteria for chronic cluster headache according to ICHD-3 beta 3.1.2.
- is able to separate cluster headache attacks from other types of headache.
- agrees to maintain current preventive headache and sleep medication regimens (no change in type, frequency, or dose) during the whole study period.
- Signed informed consent.
You may not qualify if:
- disorders with contraindications for use of continuous positive airway pressure (e.g. unable to remove the ventilation mask due to a movement disorders).
- Nightly cluster headache attacks
- Pregnancy or planned pregnancy
- Severe depression or other psychiatric disorder that may interfere with the treatment.
- Abuse of alcohol or illicit drugs.
- Other severe chronic pain conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Olavs Hospitallead
- Norwegian University of Science and Technologycollaborator
Study Sites (1)
St Olavs Hospital
Trondheim, Norway
Related Publications (1)
Gravdahl GB, Aakeroy L, Stovner LJ, Engstrom M, Muller KI, Bjork MH, Tronvik E. Continuous positive airway pressure in cluster headache: A randomized, placebo-controlled, triple-blind, crossover study. Cephalalgia. 2023 Jan;43(1):3331024221128273. doi: 10.1177/03331024221128273.
PMID: 36620891DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Geirmund Unsgård, MD PhD prof
St. Olavs Hospital
- PRINCIPAL INVESTIGATOR
Erling Tronvik, MD PhD
Norwegian University of Science and Technology
- STUDY CHAIR
Lars Jacob Stovner, MD prof
Norwegian Advisory Unit on Headaches
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 4, 2018
First Posted
January 12, 2018
Study Start
January 16, 2018
Primary Completion
August 21, 2019
Study Completion
August 21, 2019
Last Updated
March 31, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share